QR Code

Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer center

Abstract Autologous hematopoietic stem cell transplantation (auto-HCT) remains a cornerstone in relapsed Hodgkin lymphoma (HL), especially where access to novel agents is limited. We evaluated trends in outcomes after auto-HCT at King Hussein Cancer Center (KHCC) over two decades. We retrospectively...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Zaid Abdel Rahman, Abeer Yaseen, Anas Zayed, Lina Alkhdour, Mona Ribie, Albatol Alamoush, Fareed Barakat, Mohammad Alrawashdeh, Alaa Abu Fara, Khalid Halahleh, Omar Shahin, Akram Al-Ibraheem, Mohammad Ma’koseh
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Springer 2026-03-01
Rangatū:Annals of Hematology
Ngā marau:
Hodgkin lymphoma
Autologous stem cell transplantation
Salvage chemotherapy
Immune checkpoint inhibitors
Real-world outcomes
Low-and middle-income countries (LMIC)
Urunga tuihono:https://doi.org/10.1007/s00277-026-06870-z
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite